Pasithea Cash And Short Term Investments vs Cash Analysis
| KTTAW Stock | USD 0.02 0 8.97% |
Pasithea Therapeutics financial indicator trend analysis is much more than just breaking down Pasithea Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pasithea Therapeutics is a good investment. Please check the relationship between Pasithea Therapeutics Cash And Short Term Investments and its Cash accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pasithea Therapeutics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Cash And Short Term Investments vs Cash
Cash And Short Term Investments vs Cash Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pasithea Therapeutics Cash And Short Term Investments account and Cash. At this time, the significance of the direction appears to have totally related.
The correlation between Pasithea Therapeutics' Cash And Short Term Investments and Cash is 1.0. Overlapping area represents the amount of variation of Cash And Short Term Investments that can explain the historical movement of Cash in the same time period over historical financial statements of Pasithea Therapeutics Corp, assuming nothing else is changed. The correlation between historical values of Pasithea Therapeutics' Cash And Short Term Investments and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Short Term Investments of Pasithea Therapeutics Corp are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Cash And Short Term Investments i.e., Pasithea Therapeutics' Cash And Short Term Investments and Cash go up and down completely randomly.
Correlation Coefficient | 1.0 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Cash And Short Term Investments
Short Term Investments is an account in the current assets section of Pasithea Therapeutics balance sheet. This account contains Pasithea Therapeutics investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Pasithea Therapeutics Corp fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.Cash
Cash refers to the most liquid asset of Pasithea Therapeutics, which is listed under current asset account on Pasithea Therapeutics Corp balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Pasithea Therapeutics customers. The amounts must be unrestricted with restricted cash listed in a different Pasithea Therapeutics account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.Most indicators from Pasithea Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pasithea Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pasithea Therapeutics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At this time, Pasithea Therapeutics' Selling General Administrative is fairly stable compared to the past year. Issuance Of Capital Stock is likely to climb to about 31 M in 2024, whereas Sales General And Administrative To Revenue is likely to drop 16.32 in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Other Operating Expenses | 4.5M | 15.3M | 16.0M | 9.9M | Depreciation And Amortization | 1.4K | 5.1K | 648.5K | 680.9K |
Pasithea Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Pasithea Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Pasithea Stock Analysis
When running Pasithea Therapeutics' price analysis, check to measure Pasithea Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pasithea Therapeutics is operating at the current time. Most of Pasithea Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pasithea Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pasithea Therapeutics' price. Additionally, you may evaluate how the addition of Pasithea Therapeutics to your portfolios can decrease your overall portfolio volatility.